🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The safety and efficacy of pembrolizumab plus the investigator's choice of ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham-Medicine ( Site 0065)
Start Date
2021-06-18
Trial ID
NCT04895358
Treatments Being Tested
The primary purpose of this study is to assess the effect of multiple-dose ...
Status
Completed
Location
Winship Cancer Institute at Emory University
Start Date
2014-04-01
Trial ID
NCT02122770
Treatments Being Tested
The primary purpose of this study is to determine if sapanisertib in combin...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
2016-04-01
Trial ID
NCT02725268
Treatments Being Tested
This is an open-label, single-center, single-arm, dose escalation and dose ...
Status
Terminated
Location
Asan Medical Center
Start Date
2018-10-01
Trial ID
NCT03707028
Treatments Being Tested
An open-label, single oral dose of therapeutic Liporaxel and microdose 18F-...
Status
Completed
Location
Seoul National University Bundang Hospital
Start Date
2018-07-03
Trial ID
NCT04046016
Treatments Being Tested
A multi-center, open-label phase I/II study to to determine the safety and ...
Status
Completed
Location
Uniklinik Köln
Start Date
2020-05-25
Trial ID
NCT04257448
Treatments Being Tested
The goal of this clinical trial is to evaluate the efficacy and safety of o...
Status
Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-08-15
Trial ID
NCT07095023
Treatments Being Tested
Phase III Study of Capivasertib + Paclitaxel versus Placebo + Paclitaxel as...
Status
Active Not Recruiting
Location
Research Site
Start Date
2019-06-25
Trial ID
NCT03997123
Treatments Being Tested
Our hypothesis is: the nutritional supplement Ocoxin-viusid improves the qu...
Status
Completed
Location
National Institute of Oncology and Radiobiology (INOR)
Start Date
2018-10-25
Trial ID
NCT03562897
Treatments Being Tested
Determine the safety, tolerability, maximum tolerated dose (MTD), and recom...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-27
Trial ID
NCT02366949
Treatments Being Tested